Sign in

CIK 0001504776 · Large accelerated filer

Warby Parker Inc.

Sign in to watch
Ticker
WRBY
Exchange
NYSE
Industry
Ophthalmic Goods
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
800423634
Phone
(646) 847-7215
Business address
233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
Former names
JAND, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,861,485
in 5 filings, $7.9M under 10b5-1 plans

Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-09-06 Gilboa David Abraham Co-Chief Executive Officer Option exercise · Restricted Stock Units 10b5-1 −4,331 7,220
2024-09-06 Gilboa David Abraham Co-Chief Executive Officer Option exercise · Restricted Stock Units 10b5-1 −44,703 709,878
2024-09-06 Gilboa David Abraham Co-Chief Executive Officer Option exercise · Class B Common Stock 10b5-1 +49,034 6,538,087
2024-09-06 Gilboa David Abraham Co-Chief Executive Officer Conversion · Class B Common Stock 10b5-1 −27,143 6,510,944
2024-08-14 SINGER BRADLEY E Director Purchase +25,000 $12.63 $316K 125,000
2024-08-13 SINGER BRADLEY E Director Purchase +50,000 $13.00 $650K 100,000
2024-08-01 WILLIAMS RONALD A Director Grant or award +790 82,846
2024-08-01 SINGER BRADLEY E Director Grant or award +15,793 65,793
2024-06-14 D1 Capital Partners L.P. 10% owner Sale −5,500,000 $15.66 $86.1M 9,444,023
2024-06-13 Briggs Teresa Director Sale 10b5-1 −7,396 $16.31 $121K 38,859

Page 20 of 20 · 390 trades